Commercialization: Page 84
-
PharmaVoice Team/PharmaVoice
HBA Leadership Conference
1. Chicago served as the host city for the 6th Annual HBA Leadeship Conference. 2. Arlene Kirsh, GlaxoSmithKline, and Leadership Conference Chair and Director of Professional Development, Laurie Cooke, HBA CEO, and Catherine Sohn, GlaxoSmithKline, and Past WOTY, take a moment during star gazing a...
By PharmaVoice Team • Jan. 28, 2009 -
PharmaVoice Team/PharmaVoice
What Makes Great Creative Great?
Steve Frederick, Executive VP, Creative Director, FlashPoint Medica At face value, many pharmaceutical ads might be considered “interesting." But being interesting does not necessarily mean effective. In order to be “great," creative efforts must be so powerful and persuasive that they demand a r...
By Steve Frederick • Jan. 28, 2009 -
PharmaVoice Team/PharmaVoice
Process Improvement: Investigator Payments
Clinical-trial protocols are becoming more complicated, and investigators and site personnel are responding to the challenge. Yet issues about how sites are compensated for their time and effort remain. At the same time, the need to create an efficient development program that aims to bring medic...
By Denise Myshko • Jan. 28, 2009 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL William GARBARINI Jr. Ferring Promotes Head of Orthopedics and Urology Business Ferring Pharmaceuticals has promoted William Garbarini Jr. to VP of its orthopedics and urology business unit, recently formed by the merging of these clinical product areas. Mr. Garbarini was formerly exe...
By PharmaVoice Team • Jan. 28, 2009 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: Lathian Health Offers Closed-Loop Promotion Tool Informa Launches CRM/ROI Tracking Solution Verticals onDemand Offers Analytics and Reporting Solution OpenQ Unveils KOL Solutions Tibco Spotfire Solution Speeds Dru...
By PharmaVoice Team • Jan. 27, 2009 -
PharmaVoice Team/PharmaVoice
What's New
FemmePharma Global Healthcare Inc. is devoted to developing drugs for diseases and disorders disproportionately affecting women. For more information, visit femmepharma.com. The International Society for Medical Publication Professionals (ISMPP) is a not-for-profit organization for medical public...
By PharmaVoice Team • Jan. 27, 2009 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, marketing, And R&D Trends affecting the healthcare industry U.S. Biochip Market to Reach $2.5 Billion in 2012 U.S. demand for biochip products and services is forecast to grow 9.9% annually, to $2.5 billion in 2012, led by uses in drug discovery and epidemiological research. According ...
By PharmaVoice Team • Jan. 27, 2009 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
When it comes to making drugs safer, cheaper, and more effective, few fields have shown more promise than molecular diagnostics. But the full potential of this revolutionary area of medical research has yet to be reached, not because of technological barriers — although they do exist — but becaus...
By Peter Pitts • Jan. 27, 2009 -
PharmaVoice Team/PharmaVoice
Table of Contents
ON THE COVER Partnering for Success In these times of adversity, strategic alliances become even more crucial than ever for survival. FEATURES No Pens or Mugs? No Problem. The industry is discovering it won’t lose the ability to message effectively under the new PhRMA code. The Green o...
By PharmaVoice Team • Dec. 22, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Alex Gorsky Sheri McCoy Johnson & Johnson Shifts Executives Global healthcare company Johnson & Johnson has appointed Alex Gorsky worldwide chairman, surgical care group, with responsibility for the surgical franchises Ethicon, Ethicon Endo-Surgery, and DePuy, as well ...
By PharmaVoice Team • Dec. 22, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
Integromics and Tibco Spotfire Launch Genomics Data Analysis Tool GEL Interactive Platform Supports Advocate Campaign Management GEL Interactive Technologies’ new key opinion leader (KOL) management platform, OneVoice: KOL, provides the features and tools needed to help brand teams and their part...
By PharmaVoice Team • Dec. 22, 2008 -
PharmaVoice Team/PharmaVoice
What's New
Parexel Offers early-Study Support Parexel International is providing companies with dedicated support for proof-of-concept studies, which are mainly conducted in targeted patient populations and are designed to demonstrate early signals of a product’s efficacy. The goal of these studies is to he...
By PharmaVoice Team • Dec. 22, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Cost Deters Cancer Patients from Seeking Treatment In addition to considerable physical and emotional burdens, cancer patients must also shoulder costly treatments resulting from their disease. A recent Thomson Reuters survey shows that the financial repercussions of cancer are taking a toll on p...
By PharmaVoice Team • Dec. 22, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by Terry Nugent No doubt change is in the air. A new administration brings many new challenges to the pharmaceutical industry, with marketing on the front lines. The question is how to respond? Regulatory and financial pressures are constraining the promotional choices and budgets ava...
By Terry Nugent • Dec. 22, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
Milestones WOTY Award Turns 20 In 2009, the Healthcare Businesswomen’s Association (HBA) marks the 20th anniversary of its Woman of the Year award. Every year, the HBA, which is committed to increasing recognition for outstanding women in all facets of the healthcare industry, honors an outstandi...
By PharmaVoice Team • Dec. 22, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Business not as usual. This month’s Forum — Virtual Pharma: Cheaper, Faster, but Doable? — hits a chord particularly close to home to us at PharmaVOICE. Over the past eight years, we’ve witnessed more than just a few companies coming to a virtual reality. In fact, Stan Bernard of Bernard and Asso...
By Taren Grom • Dec. 22, 2008 -
PharmaVoice Team/PharmaVoice
Doctors' Choice Awards
Identifying POWERful MEDICAL ADVERTISING 6th Annual Program Generated Responses From More Than 5,700 Physicians Dusa’s ClindaReach and Pfizer’s Chantix Highest Scoring Ads ClindaReach Category: Highest-Scoring Ad (Specialist Audience) Marketer: Dusa Agency: Topin & Associates Chantix Category...
By PharmaVoice Team • Nov. 22, 2008 -
PharmaVoice Team/PharmaVoice
Patient Education
Communication Strategies PATIENT EDUCATION Old School Communications With a twist As the techno-wave continues to roll over and roll up into marketing plans, product managers still need to reach patients with branded and nonbranded educational messages that resonate on a personal level and connec...
By Taren Grom • Nov. 22, 2008 -
PharmaVoice Team/PharmaVoice
Salesforces
SALES & Marketing Salesforces The Salesforce of the Future: MORE SERVICE, LESS SELL As companies — Sanofi-Aventis, Merck, Wyeth, Schering-Plough, Novartis — continue to make headlines for collectively laying off thousands of sales representatives, the industry looks for innovative ways to do ...
By PharmaVoice Team • Nov. 22, 2008 -
PharmaVoice Team/PharmaVoice
Development
development RESEARCH & Development BY DENISE MYSHKO Models of CHANGE In the future, successful biopharmaceutical companies will be those that have reviewed R&D business models and implemented updated strategies for improving the development of new products. The pharmaceutical industry is ...
By PharmaVoice Team • Nov. 22, 2008 -
PharmaVoice Team/PharmaVoice
Early Research
RESEARCH & Development Early Research The Future of innovation Discovery and research technologies are advancing and will have a tremendous impact on the pipelines of the future. BY DENISE MYSHKO The way new medicines are discovered is on the cusp of revolutionary change. Advances in the unde...
By Denise Myshko • Nov. 22, 2008 -
PharmaVoice Team/PharmaVoice
Globalization
Corporate Strategy GLOBALIZATION BY TAREN GROM Risks and Rewards The global landscape is changing. Countries once thought of as secondary or tertiary markets are providing opportunities for not only pharmaceutical companies but for their contract research and marketing partners as well. IMS’s 200...
By Taren Grom • Nov. 22, 2008 -
PharmaVoice Team/PharmaVoice
The Corner Office
Corporate Strategy A review of the annual reports and public statements of more than two dozen of the industry’s publicly traded pharmaceutical/biotechnology companies reveals the top trends as identified by the CEOs, presidents, and executive management teams of these industry standard bearers. ...
By PharmaVoice Team • Nov. 22, 2008 -
PharmaVoice Team/PharmaVoice
Crystal Ball
LOOKING Forward The CRYSTAL BALL We asked our readers to act as prognosticators and identify the top trends that they expect to shape the industry in the coming year and beyond. Some of their responses may already be part of your strategic vision, while others may add a wrinkle to your plans. Whe...
By PharmaVoice Team • Nov. 22, 2008 -
PharmaVoice Team/PharmaVoice
At A Glance
Looking Forward At a GLANCE This special Year in Preview issue provides insights into the trends that will impact the industry in the coming year and beyond. Below are some highlights from the sectors covered in the following pages. Focus on specialty markets David Avitabile President JFK Communi...
By PharmaVoice Team • Nov. 22, 2008
Previous
